JFB swings to $3.3M Q1 loss as XTEND merger advances; material weakness disclosed

Filed July 16, 2026 · Period ending March 31, 2026 · ~2 min read

Key Changes

• high

  Net loss widened to $3.3M from $30K profit in Q1 2025, driven by $3.4M operating loss. Operating expenses surged to $4.7M from $1.5M, including $1.1M in selling/marketing (up 964%) and $2.1M increase in G&A for talent, IT, and legal costs.

  MD&A: Q1 2026 Results verify on EDGAR →
• high

  XTEND merger requires $60M closing cash (reduced from $110M in July 2026 amendment). Company plans to satisfy via warrant exercises into escrow; if shortfall, will raise additional equity. No assurance of success or that XTEND will waive condition.

  MD&A: XTEND Merger verify on EDGAR →
• high

  Material weakness disclosed: lack of segregation of duties, undetected journal entries, and draft 10-Q errors found by external auditor. Company's small size and control environment cited as root causes.

  MD&A: Internal Controls verify on EDGAR →